Ready to Participate?
Already a member?
Have a question?
Healthcare Professionals
Join the MD Analytics Healthcare Professional Market Research Panel and you will be invited to participate in paid health-related market research studies, such as online surveys, virtual interviews, and in-person focus groups.
Frequently Asked Questions about MD Analytics
MD Analytics provides market research services for the healthcare and pharmaceutical industry. We are committed to following the highest standards and care within our industry, abiding by the codes of conduct of the Canadian Research Insights Council, ESOMAR, and the Insights Association.
Why should I join the panel?
Participating in our market research studies provides opportunities for healthcare professionals to voice their opinions and inform key decisions impacting health policy and patient care. Participants also benefit from learning opportunities obtained through participating in market research and from incentives earned in exchange for their time and expert contribution.
What happens after I join?
Upon signing up to join the panel, you will be sent invitations via email to participate in online surveys, telephone interviews and/or focus groups that are relevant to your health profession and area of specialty. The study invitation will always indicate the type of study, topic, length of time required to complete the study and the incentive amount.
You decide whether a study interests you and participate as you wish. Upon completing a study, you will be paid the incentive specified.
How will my privacy be protected?
MD Analytics is committed to protecting the privacy of its research participants. When participating in our market research studies, all your responses remain anonymous and there is never any follow-up or attempt made to sell you anything.
MD Analytics is an Accredited Agency of the Canadian Research Insights Council and a member in good standing of the Insights Association. As such we are committed to going above and beyond these associations’ code of conduct, adhering to an audit every two years, to ensure we meet the highest standards.
Ready to join?
What will the content of the survey be used for and for whom?
The research sponsor and purpose will vary depending on the study. To not bias the research, we are unable to reveal their identity. However, most of our clients are multi-national pharmaceutical companies specializing in developing products and treatments for the therapeutic area of the study topic.
Are my responses anonymous?
Absolutely, your responses are anonymous. As a third-party market research firm, we never share your personal identifiable information with the research sponsor. Your responses will never be tied back to you as an individual. We always present the research findings as an aggregate between what you and your colleagues have collectively answered.
Will my name, title, or contact information be shared with research sponsors or publications?
No, we will never share that information to our clients nor any publications. If we need data from any of our physician panelists for a publication, we will state it explicitly in the first page of the survey and will ask for your consent to proceed.
How do I know if I qualify to participate?
Every online survey starts with a short eligibility section followed by the main survey. Each survey has different screening requirements, so we cannot guarantee eligibility every time. Every eligibility section will typically take from 15 seconds up to 2 minutes of your time.
What do you do with the data collected in the eligibility section?
We discard the data from the eligibility section, if you do not qualify to answer the main study questions. The data from the eligibility section is used for profiling and it is not useful for the study if it is not coupled with answers for the main survey.
How do I verify if the research is legitimate?
You can search the validity of our studies on the CRIC research verification service.
Latest Survey Data
Understanding the Impact of COVID-19 on New Pharma Product Launches
The COVID-19 pandemic had a significant impact on physicians, including how they learn about and integrate new products into their practice. While not all saw a decline, close to 1 in 3 Specialists and close to half of GPs say their use of newly launched products declined during the pandemic, primarily due to a lack of pharma presence, reduced patient volumes overall and just a general lack of comfort using new products.
COVID-19 Impact on Patient Support Programs
Patient Support Programs (PSPs) play a significant role in ensuring that patients have the best possible experience during their journey – especially in specialty therapeutic areas where treatments tend to be more expensive. The COVID-19 pandemic has made it more challenging for patients to access support and services for their medical conditions. This has put additional pressure on company-sponsored PSPs to further enhance their offerings to help patients in the best way possible. PSPs have become increasingly important for patients since the onset of the COVID-19 pandemic and as a result now have an even more significant influence on physicians’ treatment selection process.
Pandemic’s Impact on HCPs Practices and Vaccination Campaign Perceptions
The COVID-19 vaccination campaign is underway in Canada. However, the pandemic has significantly altered HCPs’ practices to date. These changes have impacted workloads, patient assessments, and interactions with pharma. A year into the pandemic, a national COVID-19 vaccination campaign is underway. This begs the question, how are Canadian HCPs doing today? What do they foresee moving forward? Our latest short survey presents the current state of HCPs’ practices in Canada and their assessment of the government’s management of COVID-19.